EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Value of Troponin T Versus I in the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis and Myositis: Rechallenge?

Valentina A Rossi iD, Joanna Gawinecka, Florentia Dimitriou, Arnold von Eckardstein, Reinhard Dummer, Frank Ruschitzka, Christian M Matter

ESC Heart Failure · 2023

DOI: 10.1002/ehf2.14360 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ESC Heart Failure, 2023. Verfasst von Valentina A Rossi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Myocarditis, Myositis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 54-year old patient with metastatic melanoma presented with asymptomatic myositis and myocarditis after combined immune checkpoint inhibitors (ICI) therapy (anti-programmed cell death receptor-1, anti-lymphocyte activating gene-3, and anti-indoleamine 2,3-dioxygenase-1). The diagnosis was based on the typical time window after ICI, recurrence upon re-challenge, elevations of CK, high-sensitive troponin T (hs-TnT) and I (hs-TnI), mild NT-proBNP increase, and positive magnetic resonance imaging criteria. Notably, hsTnI was found to more rapidly increase and fall and to be more heart-specific than TnT in the context of ICI-related myocarditis. This led to ICI therapy withdrawal and switch to a less effective systemic therapy. This case report highlights the differential value of hs-TnT and hs-TnI for diagnosis and monitoring of ICI-related myositis and myocarditis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisMyositisHumansMiddle AgedImmune Checkpoint InhibitorsTroponin THeart

Stichwörter der Autor:innen

Immune checkpoint inhibitorMyocarditisMyositisTroponin

Substanzen

Immune Checkpoint InhibitorsTroponin T

Autor:innen und Institutionen

  • Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
  • Institute of Clinical Chemistry, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
  • Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Valentina A Rossi

Zitieren

APA

Rossi, V. A., Gawinecka, J., Dimitriou, F., von Eckardstein, A., Dummer, R., Ruschitzka, F., & Matter, C. M. (2023). Value of Troponin T Versus I in the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis and Myositis: Rechallenge?. ESC Heart Failure. https://doi.org/10.1002/ehf2.14360

Vancouver

Rossi VA, Gawinecka J, Dimitriou F, von Eckardstein A, Dummer R, Ruschitzka F, et al. Value of Troponin T Versus I in the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis and Myositis: Rechallenge?. ESC Heart Failure. 2023. doi:10.1002/ehf2.14360

BibTeX
@article{Rossi2023,
  author = {Rossi, Valentina A and Gawinecka, Joanna and Dimitriou, Florentia and von Eckardstein, Arnold and Dummer, Reinhard and Ruschitzka, Frank and Matter, Christian M},
  title = {Value of Troponin T Versus I in the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis and Myositis: Rechallenge?},
  journal = {ESC Heart Failure},
  year = {2023},
  doi = {10.1002/ehf2.14360}
}
Kostenlos starten →